Evidence map›Paper›PMID 37151210›Full record

ArticleAdvanced nanobiomed research2023

Outer Membrane Vesicle-Coated Nanoparticle Vaccine Protects Against

Elisabet Bjanes, Jiarong Zhou, Tariq Qayum, Nishta Krishnan, Raymond H Zurich, Nitasha D Menon, Alexandria Hoffman, Ronnie H Fang, Liangfang Zhang, Victor Nizet

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced nanobiomed research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Data-driven Atlas ofFrontiers in cellular and infection microbiology · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Elisabet BjanesDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA.
Jiarong ZhouDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, USA.
Tariq QayumDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA.
Nishta KrishnanDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, USA.
Raymond H ZurichDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA.
Nitasha D MenonDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA.
Alexandria HoffmanDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA.
Ronnie H FangDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, USA.
Liangfang ZhangDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, USA.ORCID 0000-0003-0637-0654
Victor NizetDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA.ORCID 0000-0003-3847-0422
University of California San Diego · US

Funding

Training in the Next Generation in Respiratory ScienceT32HL134632 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, ATUL, POWELL, FRANK L. · 2017 to 2021
$2.1M
Surprising Efficacy of Discounted Antibiotics vs. MDR Gram-Negative Pathogens Occurring Through Innate Immune SensitizationR01AI145310 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KUMARASWAMY, MONIKA, NIZET, VICTOR · 2020 to 2023
$1.9M
NHLBI NIH HHS T32 HL134632NIAID NIH HHS R01 AI145310
6 · The paper itself

Abstract

The highly multidrug-resistant (MDR) Gram-negative bacterial pathogen

Indexed as

Acinetobacter baumanniimultidrug-resistant bacterial infectionnanoparticle vaccineouter membrane vesiclepneumoniasepsis

Identifiers

PMID37151210
PMCPMC10156090
OpenAlexW4312184212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.